Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 30.10.2026. Verfasst von Jung-Min Pyun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, TDP-43 Proteinopathies, Brain. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NLM NIH HHS, Alzheimer's Association.
Abstract (Originalsprache)
INTRODUCTION Limbic‐predominant age‐related TDP‐43 encephalopathy (LATE) exhibits clinical features resembling Alzheimer's disease (AD) and frequently occurs as a co‐pathology, yet there are fewer biomarkers for LATE relative to AD. METHODS We calculated polygenic risk scores for LATE‐neuropathologic change (LATE‐PRS) and performed association analysis with neuropathology ( N = 99) and longitudinal cognitive change rates ( N = 538) in Alzheimer's Disease Neuroimaging Initiative participants aged ≥ 75 years, stratified by amyloid positron emission tomography (PET) positivity status. RESULTS LATE‐PRS was significantly associated with pathologically confirmed LATE (odds ratio = 2.292, P = 0.002), independent of AD pathology. In cognitively impaired individuals, LATE‐PRS was associated with faster executive function decline in PET‐negative individuals (β = –0.002, P = 0.041), and faster memory (β = –0.002, P < 0.001) and executive function (β = –0.001, P = 0.035 ) decline in PET‐positive individuals. In the overall sample, associations were significant only in the PET‐negative individuals. DISCUSSION LATE‐PRS may serve as a potential biomarker for LATE risk and cognitive progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
- Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.
- Department of Radiology and Imaging Sciences, and the Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Kwangsik Nho
Förderung
- NIA NIH HHS
- NLM NIH HHS
- Alzheimer's Association
- Korean government (Ministry of Science and ICT
- NIH
- National Research Foundation of Korea
- National Institutes of Health
Zitieren
APA
Pyun, J. M., Park, Y. H., Shade, L. M. P., Fardo, D. W., Kim, S., Nho, K., & Alzheimer's Disease Neuroimaging Initiative (2026). Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71824
Vancouver
Pyun JM, Park YH, Shade LMP, Fardo DW, Kim S, Nho K, et al. Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71824
BibTeX
@article{Pyun2026,
author = {Pyun, Jung-Min and Park, Young Ho and Shade, Lincoln M P and Fardo, David W and Kim, SangYun and Nho, Kwangsik and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71824}
}
EUVIMED